Olivier et al. noted in a study of 1794 breast cancer patients that those with tumors harboring TP53 mutations in exons 5–8 of the gene had a worse risk of dying of breast cancer within 10 years following surgery (p < 0.0001) (Olivier et al., 2006). The gene discussed is TP53; the disease is breast carcinoma.